169 related articles for article (PubMed ID: 33846813)
1. Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cells.
You D; Jeong Y; Yoon SY; A Kim S; Kim SW; Nam SJ; Lee JE; Kim S
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846813
[TBL] [Abstract][Full Text] [Related]
2. MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Tumour Biol; 2016 Apr; 37(4):4991-9. PubMed ID: 26537583
[TBL] [Abstract][Full Text] [Related]
3. Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB).
Yan F; Wu Z; Li Z; Liu L
Med Sci Monit; 2020 Sep; 26():e922814. PubMed ID: 32920591
[TBL] [Abstract][Full Text] [Related]
4. COL8A1 enhances the invasion/metastasis in MDA-MB-231 cells via the induction of IL1B and MMP1 expression.
Sagara A; Miura S; Kobinata A; Naganawa R; Yaginuma S; Saito S; Saito R; Kominato H; Yumoto T; Sato F
Biochem Biophys Res Commun; 2023 Jan; 642():145-153. PubMed ID: 36577251
[TBL] [Abstract][Full Text] [Related]
5. Next‑generation sequencing analysis reveals that MTH‑3, a novel curcuminoid derivative, suppresses the invasion of MDA‑MB‑231 triple‑negative breast adenocarcinoma cells.
Chiu YJ; Tsai FJ; Bau DT; Chang LC; Hsieh MT; Lu CC; Kuo SC; Yang JS
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013378
[TBL] [Abstract][Full Text] [Related]
6. Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
Fan Y; Li M; Ma K; Hu Y; Jing J; Shi Y; Li E; Dong D
Cancer Biol Ther; 2019; 20(5):617-632. PubMed ID: 30462562
[TBL] [Abstract][Full Text] [Related]
7. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment.
Qian Y; Zhang J; Xu R; Li Q; Shen Q; Zhu G
Int J Biol Macromol; 2021 Jul; 183():2215-2226. PubMed ID: 34097964
[TBL] [Abstract][Full Text] [Related]
9. Celastrol inhibit the proliferation, invasion and migration of human cervical HeLa cancer cells through down-regulation of MMP-2 and MMP-9.
Zhang J; Wang R; Cheng L; Xu H
J Cell Mol Med; 2021 Jun; 25(11):5335-5338. PubMed ID: 33945201
[TBL] [Abstract][Full Text] [Related]
10. Elevated STC‑1 augments the invasiveness of triple‑negative breast cancer cells through activation of the JNK/c‑Jun signaling pathway.
Han J; Jeon M; Shin I; Kim S
Oncol Rep; 2016 Sep; 36(3):1764-71. PubMed ID: 27459971
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
[TBL] [Abstract][Full Text] [Related]
12. Bisphenol A Increases the Migration and Invasion of Triple-Negative Breast Cancer Cells via Oestrogen-related Receptor Gamma.
Zhang XL; Liu N; Weng SF; Wang HS
Basic Clin Pharmacol Toxicol; 2016 Oct; 119(4):389-95. PubMed ID: 27038254
[TBL] [Abstract][Full Text] [Related]
13. High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity.
Liu W; Xiong X; Chen W; Li X; Hua X; Liu Z; Zhang Z
Int J Oncol; 2020 Aug; 57(2):488-499. PubMed ID: 32626933
[TBL] [Abstract][Full Text] [Related]
14. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
15. Entelon
You D; Jeong Y; Yoon SY; Kim SA; Lo E; Kim SW; Lee JE; Nam SJ; Kim S
Molecules; 2021 Jun; 26(12):. PubMed ID: 34203721
[TBL] [Abstract][Full Text] [Related]
16. EGFR and MEK Blockade in Triple Negative Breast Cancer Cells.
Maiello MR; D'Alessio A; Bevilacqua S; Gallo M; Normanno N; De Luca A
J Cell Biochem; 2015 Dec; 116(12):2778-85. PubMed ID: 25959272
[TBL] [Abstract][Full Text] [Related]
17. Celastrol inhibits breast cancer cell invasion via suppression of NF-ĸB-mediated matrix metalloproteinase-9 expression.
Kim Y; Kang H; Jang SW; Ko J
Cell Physiol Biochem; 2011; 28(2):175-84. PubMed ID: 21865725
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Cell-Derived Soluble CD44 Promotes Tumor Progression by Triggering Macrophage IL1β Production.
Jang JH; Kim DH; Lim JM; Lee JW; Jeong SJ; Kim KP; Surh YJ
Cancer Res; 2020 Mar; 80(6):1342-1356. PubMed ID: 31969374
[TBL] [Abstract][Full Text] [Related]
19. Silencing Y-box binding protein-1 inhibits triple-negative breast cancer cell invasiveness via regulation of MMP1 and beta-catenin expression.
Lim JP; Nair S; Shyamasundar S; Chua PJ; Muniasamy U; Matsumoto K; Gunaratne J; Bay BH
Cancer Lett; 2019 Jun; 452():119-131. PubMed ID: 30905819
[TBL] [Abstract][Full Text] [Related]
20. Elevated IL-1β expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone.
Jeon M; Han J; Nam SJ; Lee JE; Kim S
Chem Biol Interact; 2016 Oct; 258():126-33. PubMed ID: 27567548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]